ABC | Volume 111, Nº5, November 2018

Original Article Rattanawong et al PR interval and chronic resynchronization therapy Arq Bras Cardiol. 2018; 111(5):710-719 A) All-cause mortality B) Heart failure hospitalization C) Composite outcome Meta-analysis radom-effects estimates (exponential form) Study ommited Meta-analysis radom-effects estimates (exponential form) Study ommited Meta-analysis radom-effects estimates (exponential form) Study ommited Freidman et al, 2016 Freidman et al, 2016 Januszkiewicz et al, 2015 Januszkiewicz et al, 2015 Freidman et al, 2016 Januszkiewicz et al, 2015 Olshansky et al, 2012 Rickard et al, 2017 Kronborg et al, 2009 Ying-Hsiang et al, 2014 1.01 1.08 1.34 1.67 1.91 1.04 1.13 1.21 1.30 1.36 1.06 1.16 1.30 1.45 2.43 Supplementary Document 2 – Plot of sensitivity analysis of all-cause mortality (S2A), HF hospitalization (S2B), and composite outcome (S2C). Search strategy and keywords EMBASE Searching term: 'pr interval' AND 'cardiac resynchronization therapy' AND [humans]/lim AND [english]/lim AND [clinical study]/lim Pubmed Searching term: "pr interval"[All Fields] AND "cardiac resynchronization therapy "[All Fields] NOT "case report"[All Fields] Supplementary Document 1 – Search strategy and keywords 718